Phase II study of sulofenur (LY 186641). A novel antineoplastic agent in advanced non-small cell lung cancer (Q70469321)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 February 1993
edit
Language Label Description Also known as
English
Phase II study of sulofenur (LY 186641). A novel antineoplastic agent in advanced non-small cell lung cancer
scientific article published on 01 February 1993

    Statements

    Phase II study of sulofenur (LY 186641). A novel antineoplastic agent in advanced non-small cell lung cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit